AMA statement on FDA approval of implant to fight opioid addiction

| 1 Min Read

"The AMA is pleased the FDA approved a new implantable option to help treat patients with substance use disorders. With nearly 2 million Americans needing treatment for opioid use disorder, patients will benefit from increased options for medication-assisted treatment.

 

 

Full press statement available when you sign in

Sign in to the AMA website to get the full version of this press statement. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Doctor with text bubbles and graphic elements

Deepfake “doctors” are a problem—here are 7 keys to stopping them

| 4 Min Read
Light bulb with

How to bring physician well-being initiatives to life

| 14 Min Read
Healthcare worker in empty hospital operating room

These physician specialties score highest on resident well-being

| 11 Min Read
Train passenger distressed by motion sickness

What doctors want patients to know about motion sickness

| 10 Min Read